| Value | ₹384.3 Cr |
|---|
BSE filing, NSE: SOLARA. Summary written from the filing by ALFA Finder's alert engine.
Solara Active Pharma Sciences Ltd: key numbers
- Share price
- ₹643.30
- Market cap
- ₹3,099 Cr
- Revenue (annual)
- ₹1,369 Cr
- Net profit (annual)
- ₹-7.41 Cr
- P/E (TTM)
- 83.9×Sector 37.9×
- Promoter holding
- 41.93%+0.00% QoQ
- FII holding
- 10.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Solara Active Pharma Sciences Ltd
All →Solara Active Pharma Sciences Other Announcement
Solara Active Pharma Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details equity ownership across various investor categories.
Solara Active Pharma Sciences Earnings Call Transcript: Key Takeaways
Solara delivered its best profitability in five years despite ongoing Ibuprofen pricing and raw material challenges.
Solara Active Pharma Sciences Investor Presentation: Key Takeaways
Solara's Q2 FY27 delivered record EBITDA and PAT in five years, driven by 33% revenue growth. Base business strength offset Ibuprofen headwinds, which is now nearing breakeven.
Solara Active Pharma Sciences Employee Stock Options
Solara Active Pharma Sciences Limited allotted 8,300 equity shares under its 2018 ESOP plan. The exercise of these options realized Rs. 0.31 Crore for the company.
- Value
- ₹0.31 Cr
Solara Active Pharma Sciences Q2 FY27 Results: Turns Profitable, Net Profit ₹28.5 Cr
Solara Active Pharma Sciences Ltd reported revenue from operations of ₹417.3 Cr (+33.1% YoY) and net profit of ₹28.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹28.5 Cr
Solara Active Pharma Sciences Other Announcement
Solara Active Pharma received an ESG rating of 63 ('Strong' category) from Crisil ESG Ratings for the fiscal year 2026, an upgrade from the prior year.
Other results update announcements
All →Sula Vineyards Results Update
Sula Vineyards reported Q2 FY27 net profit up 34% YoY to Rs 8.1 Crore. The release also flags a fourth hotel and upcoming product launches.
Britannia Industries Results Update
Britannia reported Q2 consolidated sales of Rs 5,542 Crore (up 16.6%) and net profit of Rs 726 Crore (up 10.8%). Six-month sales reached Rs 10,506 Crore with profit at Rs 1,319 Crore.
Kalpataru Projects International Results Update
KPIL reported record Q2 FY27 revenue of ₹7,004 Crore and PBT up 24% YoY to ₹398 Crore. Net debt fell to ₹72 Crore, with an order book of ₹71,846 Crore.
- Order book
- ₹71,846 Cr
Fortis Healthcare Results Update
Fortis Healthcare released a press release on Q2 FY27 results, with consolidated revenue of INR 2,735 Cr up 17.3%. It also disclosed the Suguna Hospital acquisition and a 400+ bed Delhi hospital services agreement.
- hospital beds acquired
- 110.0 beds
TCPL Packaging Results Update
TCPL Packaging reported strong Q2 FY27 results, with consolidated PAT up 58% year on year. It also incorporated a battery separator film subsidiary.
Venus Pipes & Tubes Results Update
Venus Pipes' results press release showed Q2 FY27 revenue up 23.9% to Rs.361.1 Crore. EBITDA margin eased to 14.3% amid freight and fuel costs.